• TRADE NAMES: Algopyrin; Analgin (BPG); Baralgin; Dipyrone; Dolo-Tiaminol; Nolotil; Novalgin
  • INDICATIONS: Analgesic, antipyretic, anti-inflammatory
  • SYNONYM: dipyrone
  • CLASS: Non-steroidal anti-inflammatory (NSAID)
  • HALF-LIFE: 2–10 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.

Parenteral administration of Analgin is contraindicated in infants <1 year old.

Metamizole is banned in more than 30 countries, including Japan, Australia, the UK and the USA.

Please login to view the rest of this drug profile.

Page last updated 03/01/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric